<DOC>
	<DOCNO>NCT00021892</DOCNO>
	<brief_summary>To assess diagnostic prognostic usefulness serum marker leave ventricular remodel predict congestive heart failure .</brief_summary>
	<brief_title>Ventricular Matrix Remodeling : Correlates Prognosis</brief_title>
	<detailed_description>BACKGROUND : Recent study establish cardiac extracellular matrix ( ECM ) remodel major determinant pathologic leave ventricular hypertrophy ( LVH ) progressive leave ventricular dilatation , result , contribute development leave ventricular dysfunction overt congestive heart failure ( CHF ) . The recent development reliable serologic assay procollagen peptide , metalloproteinases ( MMP ) tissue inhibitor ( TIMP ) , cytokines permit vivo assessment LV ECM remodeling , raise possibility expand utility marker 'from bench bedside . ' Prior study ECM biomarkers congestive heart failure limit cross-sectional investigation small sample highly select patient advanced disease . The fundamental question whether serum marker ECM remodel important correlate leave ventricular dilatation leave ventricular hypertrophy , independent predictor incident congestive heart failure community remain unanswered . DESIGN NARRATIVE : The aim study : determine relationship serum marker ECM remodel traditional congestive heart failure risk factor ; analyze cross-sectional relation marker ECM remodel echocardiographic leave ventricular hypertrophy leave ventricular dilatation , Doppler indices leave ventricular filling serum natriuretic peptide ; investigate prospectively relationship ECM remodel marker progressive leave ventricular dilatation leave ventricular hypertrophy congestive heart failure incidence , adjust standard risk factor . Stored sample Framingham Offspring Omni cohort use . Participants extremes joint distribution leave ventricular wall thickness leave ventricular internal dimension echocardiogram perform earlier Framingham exams sample .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>